Weight managementPatient guide

Mounjaro

tirzepatide

Understand your treatment. Know what to expect. Feel more confident asking questions.

On this pageThe big picture

01Understand your treatment

The big picture.

Mounjaro is a prescription medicine that can support weight loss by helping you feel less hungry. It is used alongside changes to food and activity. This guide is for adults using it for weight management, and is a starting point for a conversation with your GP.

Sources1

02How it works

Small signals. A different appetite.

It acts on two hormone receptors, called GIP and GLP-1, involved in appetite and blood sugar control. Think of them as places where your body receives messages.

Sources17
tirzepatide
GIPreceptor
GLP-1receptor
  1. 01

    Appetite signals

    You may feel satisfied sooner and less hungry between meals.

  2. 02

    Stomach emptying

    Food leaves the stomach more slowly, especially early in treatment.

  3. 03

    Blood sugar

    It helps the pancreas release insulin when blood sugar is raised.

Explore the mechanism in more detail

03Your guide

What can I expect?

In a 72-week study, adults without diabetes lost about 15–21% of their starting weight on average, depending on the dose, compared with about 3% with placebo. Both groups received support with food and activity.

These are study averages, not a promise or a personal target. Your response, side effects and health goals matter more than reaching a particular dose.

Sources5

04Your guide

Taking it week by week

Dose steps, once a week

Any increase is at least 4 weeks after the last one. Follow your own prescription; do not increase it yourself.

  1. 2.5 mgWeeks 1–4
  2. 5 mgFrom week 5
  3. 7.5 mgIf prescribed
  4. 10 mgIf prescribed
  5. 12.5 mgIf prescribed
  6. 15 mgMaximum
Sources82

The usual starting dose is 2.5 mg once weekly for 4 weeks, then 5 mg weekly. Your prescriber may increase it further in 2.5 mg steps, with at least 4 weeks between increases, up to 15 mg weekly. Follow your own prescription; do not increase it yourself.

Ask your pharmacist to demonstrate your exact device. Follow the leaflet for injection technique and storage. This guide does not teach click-counting or partial doses.

Sources82

05Your guide

If you miss a dose

Take the missed dose if there are at least 3 days until your next scheduled dose. If there are fewer than 3 days, skip it and take the next dose on your usual day. Never double up. Leave at least 72 hours between injections. If several doses are missed, ask your prescriber how to restart.

Sources2

06Your guide

Side effects: what to expect

Side effects in numbers

What does “common” look like?

In two 72-week weight-management studies, people taking Mounjaro reported the following effects. These figures combine doses and include adults with and without type 2 diabetes. Everyone in the studies also received food and activity support.

Sources1
Choose an effect to see it as 100 people

Nausea

About 1 in 4

About 28 in 100 people taking Mounjaro in the studies reported this (27.5%)

Reported nauseaDid not

Diarrhoea

About 1 in 5

About 21 in 100 people taking Mounjaro in the studies reported this (20.9%)

Reported diarrhoeaDid not

Constipation

About 1 in 7

About 14 in 100 people taking Mounjaro in the studies reported this (13.6%)

Reported constipationDid not

Vomiting

About 1 in 9

About 11 in 100 people taking Mounjaro in the studies reported this (10.8%)

Reported vomitingDid not

These are people who reported an effect during treatment, not a risk with each injection. One person could report several effects. A report does not mean the medicine caused every case. “1 in” figures and the 100-person pictures are approximate; percentages show the published values. Your experience may differ.

Other effects worth knowing about

These were also reported in the same studies. Percentages combine the treatment doses.

  • IndigestionDiscomfort after eating9.3%
  • Tummy painAbdominal pain reporting term5.2%
  • BurpingBelching4.9%
  • Hair lossHair shedding4.7%
  • DizzinessFeeling light-headed4.5%

“Tummy pain” here is one study reporting term; it does not include every type of abdominal symptom. This is a selected list, not every possible side effect. Read the medicine leaflet and discuss any concerns with your GP or pharmacist.

About the studies & rates by dose

SURMOUNT-1 and SURMOUNT-2 were randomised trials funded by the manufacturer. SURMOUNT-1 enrolled adults with obesity, or overweight plus a weight-related condition, without diabetes. SURMOUNT-2 enrolled adults with overweight or obesity and type 2 diabetes. The 72 weeks included gradual dose increases. The figures come from Table 4 of the Australian product information (September 2026).

Mounjaro: 2,519 people.

Percentage reporting each effect, by study group
Effect5 mgn = 63010 mgn = 94815 mgn = 941
Nausea24.6%29.0%28.0%
Diarrhoea18.7%20.8%22.5%
Constipation16.8%14.1%10.8%
Vomiting8.3%10.8%12.5%

The 5 mg group comes only from SURMOUNT-1; the 10 mg and 15 mg columns combine both studies. Differences therefore reflect the populations as well as the doses. These are not figures for the 2.5 mg starting dose. Do not change your dose based on this table.

Sources1
Severe symptoms? See when to get help

What can help?

Try smaller meals, stop eating when comfortably full, and avoid foods that make symptoms worse. Take regular sips of fluid. Ask your pharmacist about suitable treatment for constipation.

Digestive effects are often mild or moderate and can be more noticeable as the dose increases. Contact your GP if they persist, interfere with daily life, or affect eating or drinking. Discuss symptoms before your next dose increase; severe symptoms need assessment.

Sources129

07Know when to get help

When to get help

  • Emergency · Call 000

    Call 000 for trouble breathing, swelling of the tongue or throat, collapse, or immediate danger from thoughts of self-harm.

  • Urgent

    Seek urgent medical care for severe, lasting tummy pain (sometimes spreading to the back), repeated vomiting with inability to keep fluids down, very little urine, or tummy pain with fever or yellow skin. Do not take another dose if pancreatitis is suspected until assessed.

  • Urgent

    Severe bloating with vomiting and inability to pass stools or wind also needs urgent care.

  • Urgent

    Sudden loss of vision needs urgent assessment. Contact your GP promptly about new or worsening depression or unusual changes in mood.

Sources121011

08Plan ahead

Important conversations

Tell your GP about all medicines and health conditions, especially previous pancreatitis, severe stomach-emptying problems, kidney problems or diabetic eye disease. Insulin and some diabetes tablets can increase the risk of low blood sugar; ask for a prevention and treatment plan.

Tell the anaesthetist or procedural team before surgery or sedation. They will give you an individual plan; do not decide yourself when to withhold treatment.

Sources14

09Plan ahead

Pregnancy and contraception

Do not use Mounjaro during pregnancy. Discuss a planned pregnancy with your GP: treatment should stop at least one month beforehand. If you become pregnant, stop treatment and contact your prescriber. Discuss breastfeeding before use.

If you use the contraceptive pill, switch to a non-oral method or add condoms for 4 weeks after starting Mounjaro and for 4 weeks after every dose increase. Your GP or pharmacist can help you choose.

Sources13

10Your guide

Think beyond the first few months

Weight management often needs ongoing support. In a withdrawal study, people who stopped tirzepatide tended to regain weight, while continued treatment helped maintain weight loss.

Plan regular reviews with your GP to discuss benefits, side effects, nutrition, activity, affordability and whether treatment still suits you. Make a plan together before stopping.

Sources6